PV
Palvella Therapeutics, Inc. (PVLA)
NASDAQ·Healthcare·Biotechnology
$128.11
-0.41%
Mkt Cap $1.50B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.91 | -$1.08 | -18.53% | — | — |
| Q4 2025 Nov 11, 2025 | — | — | — | -$0.85 | -$1.03 | -21.18% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.78 | -$0.86 | -10.26% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$3.40 | -$0.74 | +78.24% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.39 | $4.00 | +1125.64% | — | — |
| Q4 2024 Nov 13, 2024 | $1.07M | — | — | -$0.55 | -$2.19 | -301.83% | — | — |
| Q3 2024 Aug 14, 2024 | $2.24M | — | — | -$2.40 | -$2.76 | -15.00% | — | — |
| Q2 2024 May 16, 2024 | $2.24M | — | — | -$4.80 | -$2.00 | +58.33% | — | — |
| Q1 2024 Mar 30, 2024 | $2.24M | $1.30M | -42.11% | -$9.60 | -$3.71 | +61.40% | — | — |
| Q4 2023 Nov 15, 2023 | $7.74M | $19.52M | +152.07% | -$8.80 | -$8.70 | +1.15% | — | — |
| Q3 2023 Aug 11, 2023 | $4.02M | $20.05M | +399.00% | -$12.54 | $3.62 | +128.88% | — | — |
| Q2 2023 May 11, 2023 | $2.72M | $1.94M | -28.77% | -$14.68 | -$1.17 | +91.99% | — | — |